VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $136 | -8.1% | 20,000 | 0.0% | 0.04% | -9.3% |
Q4 2022 | $148 | -99.9% | 20,000 | 0.0% | 0.04% | -33.8% |
Q3 2022 | $198,000 | -9.2% | 20,000 | 0.0% | 0.06% | -1.5% |
Q2 2022 | $218,000 | -3.5% | 20,000 | 0.0% | 0.07% | +10.0% |
Q1 2022 | $226,000 | -28.0% | 20,000 | 0.0% | 0.06% | -24.1% |
Q4 2021 | $314,000 | -8.5% | 20,000 | 0.0% | 0.08% | -21.0% |
Q3 2021 | $343,000 | -20.2% | 20,000 | 0.0% | 0.10% | -22.5% |
Q2 2021 | $430,000 | – | 20,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |